Mission statement · Company scope
“Our mission is to develop therapeutic drugs designed to treat neurodegenerative diseases, currently focusing on Parkinsonian and other movement disorders.”
In use2026 – now1 sighting
First seenAug 2026Added
Last seenAug 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary)
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 20 words · reading grade 20.5
- Review status
- auto accepted · classifier rules-v0
- Quality score
- 0.76
- Record
- st_cf93321f29802fdf
- Classification confidence
- 0.85
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-08-28 · sec_sentence · 20-F · accession 0001437749-26-029135
View filing ↗0 to compareCompare